Elisa Rossini

404 total citations
23 papers, 270 citations indexed

About

Elisa Rossini is a scholar working on Surgery, Cancer Research and Genetics. According to data from OpenAlex, Elisa Rossini has authored 23 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 14 papers in Cancer Research and 8 papers in Genetics. Recurrent topics in Elisa Rossini's work include Cancer, Hypoxia, and Metabolism (14 papers), Adrenal and Paraganglionic Tumors (12 papers) and Glioma Diagnosis and Treatment (8 papers). Elisa Rossini is often cited by papers focused on Cancer, Hypoxia, and Metabolism (14 papers), Adrenal and Paraganglionic Tumors (12 papers) and Glioma Diagnosis and Treatment (8 papers). Elisa Rossini collaborates with scholars based in Italy, Germany and Switzerland. Elisa Rossini's co-authors include Sandra Sigala, Andrea Abate, Salvatore Grisanti, Deborah Cosentini, Alfredo Berruti, Maurizio Memo, Martina Fragni, Constanze Hantel, Chiara Fiorentini and Guido Alberto Massimo Tiberio and has published in prestigious journals such as International Journal of Molecular Sciences, Endocrinology and International Journal of Cancer.

In The Last Decade

Elisa Rossini

23 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Rossini Italy 12 160 156 80 79 50 23 270
Andrea Abate Italy 11 162 1.0× 165 1.1× 85 1.1× 76 1.0× 25 0.5× 26 232
Laura‐Sophie Landwehr Germany 9 139 0.9× 125 0.8× 54 0.7× 70 0.9× 56 1.1× 19 239
Maria Candida Barisson Villares Fragoso Brazil 14 200 1.3× 366 2.3× 82 1.0× 309 3.9× 75 1.5× 48 500
Anne Tybjærg-Hansen Denmark 4 56 0.3× 131 0.8× 58 0.7× 84 1.1× 87 1.7× 6 319
Vania Balderrama-Brondani Brazil 9 101 0.6× 146 0.9× 35 0.4× 94 1.2× 34 0.7× 26 201
Guilherme Asmar Alencar Brazil 7 128 0.8× 232 1.5× 35 0.4× 204 2.6× 45 0.9× 9 298
Sophie Moog France 10 121 0.8× 108 0.7× 11 0.1× 103 1.3× 114 2.3× 23 304
Sandra Holzhauer United States 11 32 0.2× 66 0.4× 183 2.3× 53 0.7× 111 2.2× 16 387
Marta Laganà Italy 11 159 1.0× 193 1.2× 107 1.3× 94 1.2× 25 0.5× 37 281
Luis-Jaime Castro-Vega France 7 345 2.2× 207 1.3× 23 0.3× 156 2.0× 209 4.2× 7 469

Countries citing papers authored by Elisa Rossini

Since Specialization
Citations

This map shows the geographic impact of Elisa Rossini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Rossini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Rossini more than expected).

Fields of papers citing papers by Elisa Rossini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Rossini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Rossini. The network helps show where Elisa Rossini may publish in the future.

Co-authorship network of co-authors of Elisa Rossini

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Rossini. A scholar is included among the top collaborators of Elisa Rossini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Rossini. Elisa Rossini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rossini, Elisa, Andrea Abate, Giovanni Ribaudo, et al.. (2024). The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study. Cells. 13(5). 368–368. 4 indexed citations
2.
Rossini, Elisa, et al.. (2024). Identification and Characterisation of a Myxoma Virus Detected in the Italian Hare (Lepus corsicanus). Viruses. 16(3). 437–437. 4 indexed citations
3.
Scatolini, Maria, Salvatore Grisanti, Enrico Grosso, et al.. (2024). Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma. European Journal of Cancer. 205. 114088–114088. 4 indexed citations
4.
Abate, Andrea, Elisa Rossini, Ram Manohar Basnet, et al.. (2023). Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines. International Journal of Molecular Sciences. 24(7). 6829–6829. 6 indexed citations
5.
Ruggiero, Carmen, Elisa Rossini, Giulia Cantini, et al.. (2023). FSCN1 as a new druggable target in adrenocortical carcinoma. International Journal of Cancer. 153(1). 210–223. 11 indexed citations
6.
Rando, Maria Margherita, Federico Biscetti, Carlotta Masciocchi, et al.. (2023). Impact of COVID-19 pandemic on patients affected by peripheral arterial disease: an Italian single-center study.. PubMed. 27(20). 10144–10155. 3 indexed citations
7.
Sigala, Sandra, et al.. (2022). An update on adrenocortical cell lines of human origin. Endocrine. 77(3). 432–437. 11 indexed citations
8.
Abate, Andrea, Deborah Cosentini, Salvatore Grisanti, et al.. (2022). Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art?. Expert Opinion on Pharmacotherapy. 23(12). 1413–1424. 10 indexed citations
9.
Rossini, Elisa, Edoardo Giacopuzzi, Fabrizio Gangemi, et al.. (2021). Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α. Biomedicines. 9(6). 681–681. 10 indexed citations
10.
Rossini, Elisa, Andrea Abate, Silvia Beretta, et al.. (2021). Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer. Frontiers in Endocrinology. 12. 669426–669426. 16 indexed citations
11.
Rossini, Elisa, Andrea Abate, Martina Fragni, et al.. (2021). Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib. Clinical Genitourinary Cancer. 19(4). 316–324. 9 indexed citations
12.
Abate, Andrea, Elisa Rossini, Marta Laganà, et al.. (2021). Ribociclib Cytotoxicity Alone or Combined With Progesterone and/or Mitotane in in Vitro Adrenocortical Carcinoma Cells. Endocrinology. 163(2). 11 indexed citations
13.
Fragni, Martina, Elisa Rossini, Andrea Abate, et al.. (2019). In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆. Molecular and Cellular Endocrinology. 498. 110585–110585. 14 indexed citations
14.
Fiorentini, Chiara, Salvatore Grisanti, Deborah Cosentini, et al.. (2019). Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. Journal of Oncology. 2019. 1–7. 34 indexed citations
15.
Grisanti, Salvatore, Deborah Cosentini, Marta Laganà, et al.. (2019). Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures. Current Opinion in Endocrine and Metabolic Research. 8. 80–87. 10 indexed citations
16.
Gianoncelli, Alessandra, Martina Fragni, Elisa Rossini, et al.. (2019). Adrenocortical Carcinoma Xenograft in Zebrafish Embryos as a Model To Study the In Vivo Cytotoxicity of Abiraterone Acetate. Endocrinology. 160(11). 2620–2629. 13 indexed citations
17.
Fragni, Martina, Marco Nardini, Elisa Rossini, et al.. (2019). Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines. Naunyn-Schmiedeberg s Archives of Pharmacology. 392(6). 729–742. 9 indexed citations
18.
Fragni, Martina, Chiara Fiorentini, Elisa Rossini, et al.. (2018). In vitro antitumor activity of progesterone in human adrenocortical carcinoma. Endocrine. 63(3). 592–601. 21 indexed citations
19.
Fragni, Martina, Francesca Valcamonico, Elisa Rossini, et al.. (2017). Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity. Pharmacology. 100(5-6). 261–268. 13 indexed citations
20.
Asif, Arif, et al.. (2004). Managing metabolic complications of peritoneal dialysis. Clinical Nephrology. 62(7). 35–43. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Abate Breakdown of academic impact, for papers by Laura‐Sophie Landwehr Breakdown of academic impact, for papers by Maria Candida Barisson Villares Fragoso Breakdown of academic impact, for papers by Anne Tybjærg-Hansen Breakdown of academic impact, for papers by Vania Balderrama-Brondani Breakdown of academic impact, for papers by Guilherme Asmar Alencar Breakdown of academic impact, for papers by Sophie Moog Breakdown of academic impact, for papers by Sandra Holzhauer Breakdown of academic impact, for papers by Marta Laganà Breakdown of academic impact, for papers by Luis-Jaime Castro-Vega
Rankless by CCL
2026